• Newly Approved Drug Illuminates Ovarian Cancer Tissue

  • Dec 12 2021
  • Duración: 2 m
  • Podcast

Newly Approved Drug Illuminates Ovarian Cancer Tissue  Por  arte de portada

Newly Approved Drug Illuminates Ovarian Cancer Tissue

  • Resumen

  • The U.S. Food and Drug Administration (FDA) approved an imaging drug known as Cytalux (pafolacianine), which is attracted to ovarian cancer tissue and illuminates it when exposed to fluorescent light, allowing surgeons to more easily find and more precisely remove cancer. 

    Más Menos
activate_primeday_promo_in_buybox_DT

Lo que los oyentes dicen sobre Newly Approved Drug Illuminates Ovarian Cancer Tissue

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.